Literature DB >> 12755535

Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent Gadophrin-3.

Stephan Metz1, Heike E Daldrup-Unk, Thomas Richter, Christoph Räth, Wolfgang Ebert, Marcus Settles, Ernst J Rummeny, Thomas M Link, Morand Piert.   

Abstract

RATIONALE AND
OBJECTIVES: The authors evaluated the use of T1-weighted magnetic resonance (MR) imaging with Gadophrin-3 enhancement and of plain T2-weighted MR imaging to detect and quantify breast tumor necrosis.
MATERIALS AND METHODS: Twenty EMT-6 tumors (mouse mammary sarcoma), implanted into the mammary fat pad of BALB/c-AnNCrl mice, underwent MR imaging with plain T2-weighted and T1-weighted fast field echo sequences before and 24 hours after injection of Gadophrin-3, a new necrosis-avid contrast agent. Tumor necrosis on MR images was quantified by means of a dedicated segmentation program and was correlated with histologic findings.
RESULTS: In all tumors a central necrosis was revealed by histopathologic analysis, and central enhancement was seen with Gadophrin-3 on T1-weighted images. Small tumors (diameter, < 1 cm) showed an inhomogeneous central enhancement, whereas larger tumors (diameter, > 1 cm) enhanced mainly in the periphery of necrotic tissue. Plain T2-weighted images showed a hyperintense central area in only three of 20 cases with a large central necrosis.
CONCLUSION: Gadophrin-3-enhanced T1-weighted images are superior to plain T2-weighted images for the detection of necrosis in a murine tumor xenograft model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755535     DOI: 10.1016/s1076-6332(03)80056-9

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  13 in total

1.  Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy.

Authors:  Takayoshi Uematsu; Masako Kasami; Sachiko Yuen
Journal:  Eur Radiol       Date:  2010-05-09       Impact factor: 5.315

2.  Ultrasensitive Ultrasound Microvessel Imaging for Characterizing Benign and Malignant Breast Tumors.

Authors:  Ping Gong; Pengfei Song; Chengwu Huang; U-Wai Lok; Shanshan Tang; Yue Yu; Duane D Meixner; Kathryn J Ruddy; Karthik Ghosh; Robert T Fazzio; Wenwu Ling; Shigao Chen
Journal:  Ultrasound Med Biol       Date:  2019-09-14       Impact factor: 2.998

3.  Correlation between contrast-enhanced cone-beam breast computed tomography features and prognostic staging in breast cancer.

Authors:  Wei-Mei Ma; Jiao Li; Shuang-Gang Chen; Pei-Qiang Cai; Shen Chen; Jie-Ting Chen; Chun-Yan Zhou; Ni He; Yaopan Wu
Journal:  Br J Radiol       Date:  2022-01-07       Impact factor: 3.629

4.  Correlation Between Contrast-enhanced Ultrasound Characteristics (Qualitative and Quantitative) and Pathological Prognostic Factors in Breast Cancer.

Authors:  Irene Vraka; Evangelia Panourgias; Emmanouil Sifakis; Andreas Koureas; Petros Galanis; Dionysios Dellaportas; Athanasios Gouliamos; Aristides Antoniou
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

5.  Synthesis and characterization of a porphyrazine-Gd(III) MRI contrast agent and in vivo imaging of a breast cancer xenograft model.

Authors:  Evan R Trivedi; Zhidong Ma; Emily A Waters; Keith W Macrenaris; Rohit Subramanian; Anthony G M Barrett; Thomas J Meade; Brian M Hoffman
Journal:  Contrast Media Mol Imaging       Date:  2014 Jul-Aug       Impact factor: 3.161

6.  BI-RADS 4 breast lesions: could multi-mode ultrasound be helpful for their diagnosis?

Authors:  Gang Liu; Meng-Ke Zhang; Yan He; Yuan Liu; Xi-Ru Li; Zhi-Li Wang
Journal:  Gland Surg       Date:  2019-06

7.  Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors.

Authors:  Liat Goldshaid; Efrat Rubinstein; Alexander Brandis; Dadi Segal; Noa Leshem; Ori Brenner; Vyacheslav Kalchenko; Doron Eren; Tamar Yecheskel; Yoseph Salitra; Yoram Salomon; Avigdor Scherz
Journal:  Breast Cancer Res       Date:  2010-05-24       Impact factor: 6.466

Review 8.  Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging.

Authors:  Binghu Jiang; Jichen Wang; Yicheng Ni; Feng Chen
Journal:  Theranostics       Date:  2013-08-10       Impact factor: 11.556

9.  Adding contrast-enhanced ultrasound markers to conventional axillary ultrasound improves specificity for predicting axillary lymph node metastasis in patients with breast cancer.

Authors:  Li-Wen Du; Hong-Li Liu; Hai-Yan Gong; Li-Jun Ling; Shui Wang; Cui-Ying Li; Min Zong
Journal:  Br J Radiol       Date:  2020-12-22       Impact factor: 3.039

10.  Superb Microvascular Imaging Technology Can Improve the Diagnostic Efficiency of the BI-RADS System.

Authors:  Siman Cai; Hongyan Wang; Xiaoyan Zhang; Li Zhang; Qingli Zhu; Qiang Sun; Jianchu Li; Yuxin Jiang
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.